CHANGJIANG PHARMACEUTICAL GROUP CO., LTD.

Changjiang Pharmaceutical Group Co., Ltd.

300391

CNE100001XN8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 23/05/2024 BST			5-day change	1st Jan Change
3.39 ^CNY	+0.59%		-10.08%	-56.20%

05-08	Yichang HEC Still Negotiating Merger Deal with Sunshine Lake Pharma	MT
04-29	Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Kangyue Technology Co., Ltd. Announces Election of Zhang Tao as an Independent Director

November 14, 2017 at 02:33 pm

Kangyue Technology Co., Ltd. announced election of Zhang Tao as an independent director in its 2nd extraordinary general meeting of 2017 on 13 November 2017.

Latest news about Changjiang Pharmaceutical Group Co., Ltd.

Yichang HEC Still Negotiating Merger Deal with Sunshine Lake Pharma	05-08	MT
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma	04-09	MT
Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps	04-01	MT
YiChang HEC ChangJiang Pharmaceutical's Profit Surges in 2023	03-29	MT
Yichang Hec Changjiang Pharmaceutical Expects Up to 2,627% Profit Surge in 2023	03-13	MT
HEC ChangJiang Pharmaceutical Increases Transaction Limits Under 2 Contracts	11-08	MT
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
HEC ChangJiang Pharmaceutical's Insulin Injection Cleared for Market Launch in China	26/09/23	MT
HEC ChangJiang Pharmaceutical Returns to Profit on Surge in Anti-Viral Drug Sales	01/09/23	MT
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	22/08/23	CI
China Greenlights New Drug Application for HEC ChangJiang Pharmaceutical's Hepatitis C Drug	16/08/23	MT
HEC ChangJiang Pharmaceutical Forecasts Surge in H1 Profit; Shares Rise 5%	27/07/23	MT
Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd completed the acquisition of 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. from Changxing Shengshi Fenghua Business Co., Ltd.	24/07/23	CI
HEC ChangJiang Pharma Repurchases $400 Million Convertible Bonds Issued to Blackstone	06/07/23	MT
Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd signed Share Transfer Agreement to acquire 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. from Changxing Shengshi Fenghua Business Co., Ltd. for CNY 154.14 million.	14/06/23	CI
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/04/23	CI
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Changjiang Pharma Units Sign 359 Million Yuan Contracts	17/04/23	MT
YiChang HEC ChangJiang Pharma to Return to Profitability	20/03/23	MT
YiChang HEC ChangJiang Pharmaceutical Shareholders to Vote on Disposal of 10% Stake in Controlling Shareholder	10/03/23	MT
Kangyue Technology Adopts New Name After Shifting to Pharmaceuticals	03/03/23	MT
Kangyue Technology to Change Company Name	07/02/23	MT
Heilongjiang ZBD Pharmaceutical to Tie Up With Kangyue Technology on Medicine Supplies	06/12/22	MT

Chart Changjiang Pharmaceutical Group Co., Ltd.

Duration

Period

Chart Changjiang Pharmaceutical Group Co., Ltd.

More charts

Changjiang Pharmaceutical Group Co Ltd, formerly Kangyue Technology Co Ltd, is a China-based company principally engaged in the research and development, production and sales of drugs. The Company is engaged in three businesses. The pharmaceutical business is engaged in traditional Chinese medicine decoction pieces business, medicinal capsule business and pharmaceutical wholesale business. The internal combustion engine parts business is engaged in the research and development, production and sales of turbocharger products. The photovoltaic equipment business is engaged in the research and development, production and sales of photovoltaic equipment such as laminator and stitch welding machine.

Sector

Pharmaceuticals

Calendar

25/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHANGJIANG PHARMACEUTICAL GROUP CO., LTD.	-56.20%	164M
ELI LILLY AND COMPANY	+38.51%	727B
NOVO NORDISK A/S	+33.05%	599B
JOHNSON & JOHNSON	-6.23%	354B
MERCK & CO., INC.	+18.78%	328B
ABBVIE INC.	+1.35%	277B
ASTRAZENECA PLC	+16.00%	243B
NOVARTIS AG	+8.09%	205B
ROCHE HOLDING AG	-5.77%	203B
AMGEN INC.	+6.19%	164B

Other Pharmaceuticals

Changjiang Pharmaceutical Group Co., Ltd.

Equities

300391

CNE100001XN8

Pharmaceuticals

Kangyue Technology Co., Ltd. Announces Election of Zhang Tao as an Independent Director

Latest news about Changjiang Pharmaceutical Group Co., Ltd.

Chart Changjiang Pharmaceutical Group Co., Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Pharmaceuticals